Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Julie Paik

Title(s)Associate Professor-in-residence, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. An Observational Study of Post-hip Fracture Outcomes in Older Adults with Type 2 Diabetes. J Gen Intern Med. 2026 Jun 15. Okazaki KM, Marion LA, Burnett-Bowie SM, Cromer SJ, Ortega-Montiel J, Byrne CF, Patorno E, Paik JM, Yu EW. PMID: 42298199.
      View in: PubMed   Mentions:
    2. Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study. Diabetes Obes Metab. 2026 Jun 04. Alkabbani W, Crisafulli S, Paik JM, Tavakkoli A, Bykov K, Glynn RJ, Wexler DJ, Patorno E. PMID: 42244136.
      View in: PubMed   Mentions:    Fields:    
    3. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations. Diabetes Care. 2026 05 01; 49(5):808-817. Ostrominski JW, Ortega-Montiel J, Wexler DJ, Everett BM, Cromer SJ, Byrne CF, Glynn RJ, Paik JM, Patorno E. PMID: 41778928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Plasma metabolomic profiles and risk of hip fracture among US individuals: a nested case-control and prospective cohort study. EBioMedicine. 2026 Mar; 125:106188. Wu Z, Sun Q, Liu B, Curhan G, Avila-Pacheco J, Clish C, Zeleznik OA, Paik JM. PMID: 41762524; PMCID: PMC12962127.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Diabetic Ketoacidosis Risk in Sodium-Glucose Cotransporter-2 Inhibitors vs Glucagon-Like Peptide-1 Receptor Agonists Initiators with CKD Stages 3-4 and Type 2 Diabetes. Kidney360. 2026 Feb 02. Hansrivijit P, Patorno E, Tesfaye H, Wexler DJ, Paik JM. PMID: 41627917.
      View in: PubMed   Mentions:    Fields:    
    6. Comparative Effectiveness of Current Glucose-lowering Medications in Type 2 Diabetes Mellitus: Emulation of a Modified GRADE Trial. J Gen Intern Med. 2026 Jan 21. Ray A, Sreedhara SK, Paik JM, Cromer SJ, Bykov K, Hahn G, Glynn RJ, Wexler DJ, Patorno E. PMID: 41566094.
      View in: PubMed   Mentions:    Fields:    
    7. Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes. Diabetes Care. 2025 Dec 01; 48(12):2127-2137. Fang YE, Paik JM, Ortega-Montiel J, Tesfaye H, Wexler DJ, Patorno E. PMID: 41144235; PMCID: PMC12718078.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. Drug Saf. 2026 Apr; 49(4):471-480. Bea S, Patorno E, Hahn G, Paik JM, Wexler DJ, Bykov K. PMID: 41307830.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes. Ann Intern Med. 2026 Jan; 179(1):1-11. Crisafulli S, Alkabbani W, Paik JM, Bykov K, Tavakkoli A, Glynn RJ, Htoo PT, Yu EW, Trifirò G, Wexler DJ, Patorno E. PMID: 41183330; PMCID: PMC12718079.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population-based study. Diabetes Obes Metab. 2026 Feb; 28(2):1517-1528. Tesfaye H, Paik JM, Wexler DJ, Hathaway JT, Yu EW, Freedman A, Rizzo JF, Patorno E. PMID: 41104517; PMCID: PMC12718077.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes. Diabetes Obes Metab. 2026 Jan; 28(1):324-336. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Glynn RJ, DiCesare E, Freedman A, Schmedt N, Shay C, Paik JM, Patorno E. PMID: 41090391.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Machine learning for predicting cardiovascular events in older adults with type 2 diabetes using Medicare claims and electronic health records. J Clin Epidemiol. 2025 Dec; 188:112001. Htoo PT, Paik JM, Everett BM, Glynn RJ, Bykov K, Hahn G, Liu J, Wexler DJ, Patorno E. PMID: 41016516; PMCID: PMC12787826.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. The Association of Bone-related Biomarkers With Incident Hip Fracture: A Nested Case-control Study. J Endocr Soc. 2025 Oct; 9(10):bvaf148. Cromer SJ, Yu EW, Patorno E, Curhan GC, Paik JM. PMID: 41050357; PMCID: PMC12492103.
      View in: PubMed   Mentions:
    14. Overall Uptake and Racial, Ethnic, and Socioeconomic Disparities in the Use of Continuous Glucose Monitoring Devices Among Insulin-Treated Older Adults With Type 2 Diabetes. Diabetes Care. 2025 Aug 01; 48(8):1377-1385. Alkabbani W, Cromer SJ, Kim DH, Paik JM, Bykov K, Munshi M, Wexler DJ, Patorno E. PMID: 40445849; PMCID: PMC12718080.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes. Kidney Med. 2025 Jun; 7(6):101013. Hansrivijit P, Ortega-Montiel J, Wexler DJ, Patorno E, Paik JM. PMID: 40510603; PMCID: PMC12152630.
      View in: PubMed   Mentions: 3  
    16. Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study. Ann Intern Med. 2025 May; 178(5):620-633. Ostrominski JW, Ortega-Montiel J, Tesfaye H, Alix C, DiCesare E, Cromer SJ, Wexler DJ, Paik JM, Patorno E. PMID: 40228298; PMCID: PMC12718076.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes. JAMA Intern Med. 2025 Apr 01; 185(4):399-410. Ray A, Paik JM, Wexler DJ, Sreedhara SK, Bykov K, Feldman WB, Patorno E. PMID: 39928303; PMCID: PMC11811870.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Evidence on the benefits of statins for CVD prevention in older adults with CKD. Lancet Healthy Longev. 2025 Mar; 6(3):100698. Orkaby AR, Paik JM. PMID: 40058390.
      View in: PubMed   Mentions:    Fields:    
    19. Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors. JAMA Intern Med. 2025 Mar 01; 185(3):302-313. Shin H, Paik JM, Everett BM, DiCesare E, Alix C, Glynn RJ, Wexler DJ, Patorno E. PMID: 39836397; PMCID: PMC11877166.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study. Diabetes Obes Metab. 2025 Jun; 27(6):3503-3508. Tesfaye H, Paik JM, Zakoul H, Schmedt N, Wexler DJ, Patorno E. PMID: 40019137; PMCID: PMC12049256.
      View in: PubMed   Mentions:    Fields:    
    21. Changes in serum creatinine during and after pregnancy in female patients with or without chronic kidney disease: an observational study in UK primary care data. J Nephrol. 2025 Jun; 38(5):1509-1515. Marxer CA, Paik JM, Zhuo M, Desai RJ, Hagberg KW, Jick SS, Meier CR, Spoendlin J. PMID: 40011406; PMCID: PMC12289759.
      View in: PubMed   Mentions: 1     Fields:    
    22. Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States. J Clin Med. 2025 Jan 20; 14(2). Hansrivijit P, Tesfaye H, Wexler DJ, Abdi R, Patorno E, Paik JM. PMID: 39860655; PMCID: PMC11766230.
      View in: PubMed   Mentions:
    23. Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes. JAMA Ophthalmol. 2025 Jan 01; 143(1):62-71. Tesfaye H, Paik JM, Roh M, Htoo PT, Zakoul H, Schmedt N, Koeneman L, Wexler DJ, Patorno E. PMID: 39636645; PMCID: PMC11622102.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Fracture in Association with Anticoagulant Therapy in Patients with CKD and Atrial Fibrillation. Clin J Am Soc Nephrol. 2025 Jan 01; 20(1):31-38. Khan NF, Kim SC, Lee SB, Bykov K, Paik JM. PMID: 39665574; PMCID: PMC11737451.
      View in: PubMed   Mentions:    Fields:    
    25. Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes. Diabetes Care. 2024 11 01; 47(11):1900-1907. Htoo PT, NajafZadeh M, Tesfaye H, Schneeweiss S, Wexler DJ, Glynn RJ, Schmedt N, Déruaz-Luyet A, Koeneman L, Paik JM, Patorno E. PMID: 38917305; PMCID: PMC11502532.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. 2024 10 22; 387:e080340. Alkabbani W, Suissa K, Gu KD, Cromer SJ, Paik JM, Bykov K, Hobai I, Thompson CC, Wexler DJ, Patorno E. PMID: 39438043; PMCID: PMC11494456.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    27. Bariatric surgery and all-cause mortality: A methodological review of studies using a non-surgical comparator. Diabetes Obes Metab. 2024 10; 26(10):4273-4280. Suissa K, Schneeweiss S, Glynn RJ, Wexler DJ, Suissa S, Paik JM, Patorno E. PMID: 39014528; PMCID: PMC11800116.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice-Reply. JAMA Intern Med. 2024 Jul 01; 184(7):852-853. Paik JM, Patorno E. PMID: 38805217.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study. BMJ. 2024 06 26; 385:e078483. Fu EL, Wexler DJ, Cromer SJ, Bykov K, Paik JM, Patorno E. PMID: 38925801; PMCID: PMC11200155.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study. J Gen Intern Med. 2024 08; 39(10):1870-1879. Tesfaye H, Wang KM, Zabotka LE, Wexler DJ, Schmedt N, Koeneman L, Seman L, Paik JM, Patorno E. PMID: 38710868; PMCID: PMC11282041.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia. 2024 Jul; 67(7):1328-1342. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38509341.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    32. Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovasc Diabetol. 2024 Mar 18; 23(1):103. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38500096; PMCID: PMC10949568.
      View in: PubMed   Mentions:    Fields:    
    33. Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes. JAMA Intern Med. 2024 Mar 01; 184(3):265-274. Paik JM, Tesfaye H, Curhan GC, Zakoul H, Wexler DJ, Patorno E. PMID: 38285598; PMCID: PMC10825784.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    34. Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovasc Diabetol. 2024 02 08; 23(1):57. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38331813; PMCID: PMC10854040.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    35. A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes. Kidney Int. 2024 03; 105(3):618-628. Fu EL, Mastrorilli J, Bykov K, Wexler DJ, Cervone A, Lin KJ, Patorno E, Paik JM. PMID: 38101515; PMCID: PMC10922914.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease. JAMA Netw Open. 2023 12 01; 6(12):e2346373. Barayev O, Hawley CE, Wellman H, Gerlovin H, Hsu W, Paik JM, Mandel EI, Liu CK, Djoussé L, Gaziano JM, Gagnon DR, Orkaby AR. PMID: 38055276; PMCID: PMC10701610.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    37. Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk. J Gerontol A Biol Sci Med Sci. 2023 12 01; 78(12):2426-2434. Htoo PT, Paik JM, Alt E, Kim DH, Wexler DJ, Kim SC, Patorno E. PMID: 36866496; PMCID: PMC10692415.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Stratified analysis in comparative effectiveness studies that emulate randomized trials. Pharmacoepidemiol Drug Saf. 2024 01; 33(1):e5716. Htoo PT, Glynn RJ, Wang S, Paik JM, Schneeweiss S, Walker AM, Patorno E. PMID: 37876341.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study. Am J Kidney Dis. 2024 03; 83(3):293-305.e1. Fu EL, Desai RJ, Paik JM, Kim DH, Zhang Y, Mastrorilli JM, Cervone A, Lin KJ. PMID: 37839687; PMCID: PMC12032583.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    40. Types of dairy foods and risk of fragility fracture in the prospective Nurses' Health Study cohort. Am J Clin Nutr. 2023 12; 118(6):1172-1181. Yuan M, Hu FB, Li Y, Cabral HJ, Das SK, Deeney JT, Zhou X, Paik JM, Moore LL. PMID: 37777015; PMCID: PMC10797505.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    41. What matters most to older adults: Racial and ethnic considerations in values for current healthcare planning. J Am Geriatr Soc. 2023 10; 71(10):3254-3266. Heintz HL, Paik JM, Baird L, Driver JA, Moye J. PMID: 37528798; PMCID: PMC11497067.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Nurse-led supportive Coordinated Transitional Care (CTraC) program improves care for veterans with serious illness. J Am Geriatr Soc. 2023 11; 71(11):3445-3456. Madrigal C, Radlicz C, Hayes B, Gosian J, Jensen LL, Skarf LM, Hawley CE, Moye J, Kind AJ, Paik JM, Driver JA. PMID: 37449880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. 2023 10; 25(10):2980-2988. Abrahami D, D'Andrea E, Yin H, Kim SC, Paik JM, Wexler D, Azoulay L, Patorno E. PMID: 37395339; PMCID: PMC10527897.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    44. Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD. Curr Opin Nephrol Hypertens. 2023 07 01; 32(4):324-329. Kaze AD, Patorno E, Paik JM. PMID: 37195239.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials. JAMA. 2023 04 25; 329(16):1376-1385. Wang SV, Schneeweiss S, RCT-DUPLICATE Initiative, Franklin JM, Desai RJ, Feldman W, Garry EM, Glynn RJ, Lin KJ, Paik J, Patorno E, Suissa S, D'Andrea E, Jawaid D, Lee H, Pawar A, Sreedhara SK, Tesfaye H, Bessette LG, Zabotka L, Lee SB, Gautam N, York C, Zakoul H, Concato J, Martin D, Paraoan D, Quinto K. PMID: 37097356; PMCID: PMC10130954.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    46. Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations. J Am Soc Nephrol. 2023 07 01; 34(7):1241-1251. Fu EL, Levey AS, Coresh J, Elinder CG, Rotmans JI, Dekker FW, Paik JM, Barany P, Grams ME, Inker LA, Carrero JJ. PMID: 36995139; PMCID: PMC10356168.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    47. A Novel Chronic Kidney Disease Phenotyping Algorithm Using Combined Electronic Health Record and Claims Data. Clin Epidemiol. 2023; 15:299-307. Mansour O, Paik JM, Wyss R, Mastrorilli JM, Bessette LG, Lu Z, Tsacogianis T, Lin KJ. PMID: 36919110; PMCID: PMC10008306.
      View in: PubMed   Mentions: 3  
    48. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels. JAMA Intern Med. 2023 03 01; 183(3):242-254. D'Andrea E, Wexler DJ, Kim SC, Paik JM, Alt E, Patorno E. PMID: 36745425; PMCID: PMC9989905.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    49. Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study. Clin J Am Soc Nephrol. 2023 05 01; 18(5):592-601. Fu EL, D'Andrea E, Wexler DJ, Patorno E, Paik JM. PMID: 36827225; PMCID: PMC10278835.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    50. Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population. Nephrol Dial Transplant. 2023 Jan 23; 38(1):119-128. Fu EL, Coresh J, Grams ME, Clase CM, Elinder CG, Paik J, Ramspek CL, Inker LA, Levey AS, Dekker FW, Carrero JJ. PMID: 35689668; PMCID: PMC9869854.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    51. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics. JAMA Netw Open. 2022 10 03; 5(10):e2237606. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Najafzadeh M, Koeneman L, Farsani SF, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 36264574; PMCID: PMC9585433.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2022 10 03; 5(10):e2235995. Zhuo M, D'Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Patorno E. PMID: 36219443; PMCID: PMC9554705.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    53. Trauma re-engagement and PTSD in older medically ill veterans: implications for trauma-informed care. Aging Ment Health. 2023 05; 27(5):957-964. Moye J, O'Malley KA, Auguste EJ, Driver JA, Owsiany MT, Paik JM. PMID: 35603825; PMCID: PMC10281592.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer. J Card Fail. 2022 09; 28(9):1414-1423. Zhuo M, Kim SC, Patorno E, Paik JM. PMID: 35470055.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    55. Assessing What Matters Most in Older Adults With Multicomplexity. Gerontologist. 2022 04 20; 62(4):e224-e234. Moye J, Driver JA, Owsiany MT, Chen LQ, Whitley JC, Auguste EJ, Paik JM. PMID: 34043004; PMCID: PMC8982330.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    56. Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease. Clin Diabetes. 2022; 40(2):158-167. Swanner AA, Hawley CE, Li K, Triantafylidis LK, Li J, Paik JM. PMID: 35669297; PMCID: PMC9160537.
      View in: PubMed   Mentions: 1  
    57. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022 03 23; 21(1):47. Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. PMID: 35321742; PMCID: PMC9491404.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    58. Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries. Diabetes Care. 2022 03 01; 45(3):604-613. Hawley CE, Lauffenburger JC, Paik JM, Wexler DJ, Kim SC, Patorno E. PMID: 35043165; PMCID: PMC8918201.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    59. Self-reported sleep characteristics and risk for incident vertebral and hip fracture in women. Sleep Health. 2022 04; 8(2):234-241. Huang T, Redline S, Gordon CM, Schernhammer E, Curhan GC, Paik JM. PMID: 35241403; PMCID: PMC8995338.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Corrigendum to: Updating and Validating the U.S. Veterans Affairs Frailty Index: Transitioning From ICD-9 to ICD-10. J Gerontol A Biol Sci Med Sci. 2022 Feb 03; 77(2):e107. Cheng D, DuMontier C, Yildirim C, Charest B, Hawley CE, Zhuo M, Paik JM, Yaksic E, Gaziano JM, Do N, Brophy M, Cho K, Kim DH, Driver JA, Fillmore NR, Orkaby AR. PMID: 34272940; PMCID: PMC8824613.
      View in: PubMed   Mentions: 3     Fields:    
    61. Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022 01 01; 79(1):24-32. Katz IR, Rogers MP, Lew R, Thwin SS, Doros G, Ahearn E, Ostacher MJ, DeLisi LE, Smith EG, Ringer RJ, Ferguson R, Hoffman B, Kaufman JS, Paik JM, Conrad CH, Holmberg EF, Boney TY, Huang GD, Liang MH, Li+ plus Investigators. PMID: 34787653; PMCID: PMC8600458.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    62. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022 04; 31(4):467-475. Paik JM, Patorno E, Zhuo M, Bessette LG, York C, Gautam N, Kim DH, Kim SC. PMID: 34908211; PMCID: PMC8917076.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    63. Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes Obes Metab. 2022 03; 24(3):442-454. Patorno E, Pawar A, Wexler DJ, Glynn RJ, Bessette LG, Paik JM, Najafzadeh M, Brodovicz KG, Déruaz-Luyet A, Schneeweiss S. PMID: 34729891; PMCID: PMC8939295.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    64. Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017. Am J Nephrol. 2021; 52(12):919-928. Paik JM, Zhuo M, York C, Tsacogianis T, Kim SC, Desai RJ. PMID: 34814147; PMCID: PMC8979193.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    65. SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes. Am J Kidney Dis. 2022 06; 79(6):858-867.e1. Zhuo M, Paik JM, Wexler DJ, Bonventre JV, Kim SC, Patorno E. PMID: 34762974; PMCID: PMC9079190.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    66. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021 10 01; 4(10):e2130762. Zhuo M, Hawley CE, Paik JM, Bessette LG, Wexler DJ, Kim DH, Tong AY, Kim SC, Patorno E. PMID: 34705014; PMCID: PMC8552056.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    67. Use of Anticoagulants and Dosing Appropriateness of Apixaban for New-Onset Atrial Fibrillation Among Hemodialysis Patients. Am J Kidney Dis. 2022 06; 79(6):909-912. Zhuo M, Paik JM, Tsacogianis TN, Desai RJ. PMID: 34571068.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease, a Cohort Study. Diabetes Care. 2021 Aug 03. Harris ST, Patorno E, Zhuo M, Kim SC, Paik JM. PMID: 34344714; PMCID: PMC8929186.
      View in: PubMed   Mentions: 25     Fields:    
    69. Updating and Validating the U.S. Veterans Affairs Frailty Index: Transitioning From ICD-9 to ICD-10. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1318-1325. Cheng D, DuMontier C, Yildirim C, Charest B, Hawley CE, Zhuo M, Paik JM, Yaksic E, Gaziano JM, Do N, Brophy M, Cho K, Kim DH, Driver JA, Fillmore NR, Orkaby AR. PMID: 33693638; PMCID: PMC8202143.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    70. Osteoporosis, bisphosphonate use, and risk of moderate or worse hearing loss in women. J Am Geriatr Soc. 2021 11; 69(11):3103-3113. Curhan SG, Stankovic K, Halpin C, Wang M, Eavey RD, Paik JM, Curhan GC. PMID: 34028002; PMCID: PMC8595486.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Polypill in Persons without Cardiovascular Disease. N Engl J Med. 2021 04 29; 384(17):1673-1674. Gallieni M, Paik JM, Fiorina P. PMID: 33913648.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Opioid Use in the Nondialysis Chronic Kidney Disease Population. Semin Nephrol. 2021 01; 41(1):33-41. Zhuo M, Triantafylidis LK, Li J, Paik JM. PMID: 33896472.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Introduction: Opioids and the Kidney. Semin Nephrol. 2021 01; 41(1):1. Paik JM. PMID: 33896467.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Differential Diagnoses and Clinical Implications of Medication Nonadherence in Older Patients with Chronic Kidney Disease: A Review. Drugs Aging. 2020 12; 37(12):875-884. Owsiany MT, Hawley CE, Paik JM. PMID: 33030671; PMCID: PMC8581818.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Rapid Integration of Home Telehealth Visits Amidst COVID-19: What Do Older Adults Need to Succeed? J Am Geriatr Soc. 2020 11; 68(11):2431-2439. Hawley CE, Genovese N, Owsiany MT, Triantafylidis LK, Moo LR, Linsky AM, Sullivan JL, Paik JM. PMID: 32930391; PMCID: PMC8554768.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansPHPublic Health
    76. Obstructive Sleep Apnea and Risk for Incident Vertebral and Hip Fracture in Women. J Bone Miner Res. 2020 11; 35(11):2143-2150. Huang T, Tworoger SS, Redline S, Curhan GC, Paik JM. PMID: 32909307; PMCID: PMC7719618.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    77. Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2020 11 06; 15(11):1678-1688. Li J, Albajrami O, Zhuo M, Hawley CE, Paik JM. PMID: 32518100; PMCID: PMC7646234.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    78. A Pilot Study Embedding Clinical Pharmacists Within an Interprofessional Nephrology Clinic for the Initiation and Monitoring of Empagliflozin in Diabetic Kidney Disease. J Pharm Pract. 2021 Jun; 34(3):428-437. Triantafylidis LK, Hawley CE, Fagbote C, Li J, Genovese N, Paik JM. PMID: 31550992; PMCID: PMC8148072.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing. Clin Kidney J. 2019 Oct; 12(5):620-628. Li J, Fagbote CO, Zhuo M, Hawley CE, Paik JM. PMID: 31583087; PMCID: PMC6768299.
      View in: PubMed   Mentions: 10  
    80. BMI, Waist Circumference, and Risk of Incident Vertebral Fracture in Women. Obesity (Silver Spring). 2019 09; 27(9):1513-1519. Paik JM, Rosen HN, Katz JN, Rosner BA, Rimm EB, Gordon CM, Curhan GC. PMID: 31318497; PMCID: PMC6707901.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    81. The Burden of Frailty Among U.S. Veterans and Its Association With Mortality, 2002-2012. J Gerontol A Biol Sci Med Sci. 2019 07 12; 74(8):1257-1264. Orkaby AR, Nussbaum L, Ho YL, Gagnon D, Quach L, Ward R, Quaden R, Yaksic E, Harrington K, Paik JM, Kim DH, Wilson PW, Gaziano JM, Djousse L, Cho K, Driver JA. PMID: 30307533; PMCID: PMC6625596.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    82. Opioid Management in Older Adults with Chronic Kidney Disease: A Review. Am J Med. 2019 12; 132(12):1386-1393. Owsiany MT, Hawley CE, Triantafylidis LK, Paik JM. PMID: 31295441; PMCID: PMC6917891.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    83. The missing piece: Clinical pharmacists enhancing the interprofessional nephrology clinic model. J Am Pharm Assoc (2003). 2019 Sep - Oct; 59(5):727-735. Hawley CE, Triantafylidis LK, Paik JM. PMID: 31231002; PMCID: PMC8150925.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    84. Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis. JAMA Intern Med. 2019 06 01; 179(6):741-749. Spoendlin J, Paik JM, Tsacogianis T, Kim SC, Schneeweiss S, Desai RJ. PMID: 31058913; PMCID: PMC6503544.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    85. The Role of Deprescribing in Older Adults with Chronic Kidney Disease. Drugs Aging. 2018 11; 35(11):973-984. Triantafylidis LK, Hawley CE, Perry LP, Paik JM. PMID: 30284120; PMCID: PMC8150926.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    86. Association of Cold Ischemia Time With Acute Renal Transplant Rejection. Transplantation. 2018 07; 102(7):1188-1194. Postalcioglu M, Kaze AD, Byun BC, Siedlecki A, Tullius SG, Milford EL, Paik JM, Abdi R. PMID: 29346257; PMCID: PMC6023749.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    87. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis. Am J Kidney Dis. 2018 08; 72(2):178-187. Spoendlin J, Schneeweiss S, Tsacogianis T, Paik JM, Fischer MA, Kim SC, Desai RJ. PMID: 29891194.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    88. Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women. Calcif Tissue Int. 2018 10; 103(4):380-387. Paik JM, Rosen HN, Gordon CM, Curhan GC. PMID: 29754277; PMCID: PMC6231994.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 11; 24(11):2344-2353. Postalcioglu M, Kim HT, Obut F, Yilmam OA, Yang J, Byun BC, Kupiec-Weglinski S, Soiffer R, Ritz J, Antin JH, Alyea E, Koreth J, Cutler C, Armand P, Paik JM, Leaf DE, Ho VT, Abdi R. PMID: 29758394; PMCID: PMC6230502.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    90. A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporos Int. 2018 01; 29(1):31-39. Kaze AD, Rosen HN, Paik JM. PMID: 29098347.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    91. Body Size and the Risk of Primary Hyperparathyroidism in Women: A Cohort Study. J Bone Miner Res. 2017 Sep; 32(9):1900-1906. Vaidya A, Curhan GC, Paik JM, Wang M, Taylor EN. PMID: 28488734; PMCID: PMC5555811.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    92. Gout and Risk of Fracture in Women: A Prospective Cohort Study. Arthritis Rheumatol. 2017 02; 69(2):422-428. Paik JM, Kim SC, Feskanich D, Choi HK, Solomon DH, Curhan GC. PMID: 27589491; PMCID: PMC5274565.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    93. Gout and the Risk of Non-vertebral Fracture. J Bone Miner Res. 2017 Feb; 32(2):230-236. Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH. PMID: 27541696; PMCID: PMC5292077.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    94. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med. 2016 Dec; 129(12):1299-1306. Paik JM, Rosen HN, Gordon CM, Curhan GC. PMID: 27542612; PMCID: PMC5118092.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    95. Physical Activity and the Risk of Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2016 04; 101(4):1590-7. Vaidya A, Curhan GC, Paik JM, Wang M, Taylor EN. PMID: 26812691; PMCID: PMC4880164.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    96. Nephrolithiasis and Risk of Incident Bone Fracture. J Urol. 2016 May; 195(5):1482-1486. Taylor EN, Feskanich D, Paik JM, Curhan GC. PMID: 26707509; PMCID: PMC4870104.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    97. Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2015 Jun; 100(6):2396-404. Vaidya A, Curhan GC, Paik JM, Kronenberg H, Taylor EN. PMID: 25885946; PMCID: PMC4454810.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    98. Clinical problem solving: Itching for a diagnosis. N Engl J Med. 2015 Mar 05; 372(10):964-8. Schaefer L, Paik JM, Rennke H, Levy BD, Loscalzo J. PMID: 25738673.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    99. Interactive medical case. Itching for a diagnosis. N Engl J Med. 2015 Feb 12; 372(7):e10. Schaefer L, Vaidya A, Rennke HG, Paik J. PMID: 25671274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014 Aug; 25(8):2047-56. Paik JM, Curhan GC, Sun Q, Rexrode KM, Manson JE, Rimm EB, Taylor EN. PMID: 24803331; PMCID: PMC4102630.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    101. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ. 2012 Oct 17; 345:e6390. Paik JM, Curhan GC, Taylor EN. PMID: 23080543; PMCID: PMC3475985.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    102. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2012 Jun; 23(6):1727-36. Paik JM, Farwell WR, Taylor EN. PMID: 21932115; PMCID: PMC3741045.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    103. Determinants of plasma parathyroid hormone levels in young women. Calcif Tissue Int. 2010 Sep; 87(3):211-7. Paik JM, Curhan GC, Forman JP, Taylor EN. PMID: 20631996; PMCID: PMC3079245.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    Julie's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-34-g86efa0e9 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California